It has been about a month since the last earnings report for Medtronic (MDT). Shares have lost about 2% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the ...

Nobody said value investing was easy, as stocks can be undervalued for an extended period of time. This is similar to how they can be overvalued for a prolonged period, as with many AI names today.

Medtronic (MDT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most ...

Medtronic Plc (NYSE: MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase ...

Medtronic's growth has stalled in recent years. The company is bringing new products to market. Medtronic is also zeroing in on its most profitable businesses. Medtronic is one of the largest medical ...

The storied medical device specialist always seems to post encouraging growth. The list of Dividend Kings-- the very few U.S.-traded stocks that have enacted dividend raises at least once annually for ...

I think we'll kick things off. Thanks so much, everybody. Day 1 Morgan Stanley Global Healthcare Conference. Thanks, everybody, for coming. Patrick Wood, obviously, I run the U.S. MedTech team here.

Medtronic (NYSE:MDT) will report earnings on Tuesday, August 19, 2025. Over the last five years, the stock’s next-day move following results has been highly unpredictable: it posted a positive one-day ...

This year MDT, known for their many precision rifle chassis, introduced the MDT CRBN stock — a carbon-fiber drop-in stock that’s just at home in competition as in the backcountry. Since it hit the ...